People
Executives, founders, board members, and scientific advisors across the CNS drug developers we track. Advisors and consultants who serve multiple companies are linked across each — the overlap is the competitive-intelligence signal. 543 people indexed.
| Name | Role | Companies | Companies |
|---|---|---|---|
| Maurizio Fava, M.D. | Scientific Advisor · Advisor | Autobahn Therapeutics, Inc., Axsome Therapeutics, Inc., Definium Therapeutics, Inc., Helus Pharma, LB Pharmaceuticals Inc., Vistagen Therapeutics, Inc. | 6 |
| Cosmo Feilding Mellen | Co-Founder · Founder | Atai Beckley N.V. (AtaiBeckley), Beckley Psytech Limited | 2 |
| Seth Lederman, MD | Co-Founder · Founder | Tonix Pharmaceuticals Holding Corp. | 1 |
| Sharon Mates, PhD | Co-Founder · Founder | Intra-Cellular Therapies, Inc., Seaport Therapeutics, Inc. | 2 |
| Amit Etkin, MD, PhD | Founder · Founder | Alto Neuroscience, Inc. | 1 |
| Dan Iosifescu, MD | Scientific Advisor · Advisor | Autobahn Therapeutics, Inc., Axsome Therapeutics, Inc., Transcend Therapeutics, Inc. | 3 |
| Eric So, LLB | Co-Founder · Founder | Helus Pharma | 1 |
| Herriot Tabuteau, MD | Founder · Founder | Axsome Therapeutics, Inc. | 1 |
| Joseph Araujo | Co-Founder · Founder | Mindset Pharma Inc. | 1 |
| Kevin McCarthy, B.S., MBA | President and Chief Executive Officer · Executive | Pherin Pharmaceuticals, Inc. | 1 |
| Kristina Burow, MBA, M.A. | Co-Founder · Founder | Neumora Therapeutics, Inc., Autobahn Therapeutics, Inc. | 2 |
| Laxminarayan Bhat, PhD | Founder · Founder | Reviva Pharmaceuticals Holdings, Inc. | 1 |
| Mihael H. Polymeropoulos, MD | Co-Founder · Founder | Vanda Pharmaceuticals Inc. | 1 |
| Paul L. Berns, B.S. | Co-Founder · Founder | Neumora Therapeutics, Inc. | 1 |
| Pier Vincenzo Piazza, MD | Co-Founder · Founder | Aelis Farma S.A. | 1 |
| Richard F. Pops | Chief Executive Officer · Executive | Alkermes plc, Neurocrine Biosciences, Inc. | 2 |
| Thomas Laughren, M.D. | Depression Scientific Advisory Board Member · Advisor | Axsome Therapeutics, Inc., Helus Pharma, Vistagen Therapeutics, Inc. | 3 |
| Vimal Mehta, Ph.D. | Co-Founder · Founder | BioXcel Therapeutics, Inc. | 1 |
| Vlad Coric, MD | Co-Founder · Founder | Biohaven Ltd. | 1 |
| Amanda Feilding | Co-Founder · Founder | Beckley Psytech Limited | 1 |
| Andrew J. Cutler, MD | Scientific Advisor · Advisor | Autobahn Therapeutics, Inc., Helus Pharma | 2 |
| Andrew S. Plump, MD, PhD | President, Research & Development · Executive | Takeda Pharmaceutical Company Limited | 1 |
| Brett P. Monia, PhD | Chief Executive Officer · Executive | Ionis Pharmaceuticals, Inc. | 1 |
| Christian Angermayer | Founder · Founder | Atai Beckley N.V. (AtaiBeckley) | 1 |
| Dan Segal, MSc | Co-founder · Founder | Alto Neuroscience, Inc. | 1 |
| Derek Small, B.S. | Co-founder and Chief Executive Officer · Founder | Syndeio Biosciences, Inc. | 1 |
| Florian Schoenharting | Co-Founder · Founder | GH Research PLC | 1 |
| Freda Lewis-Hall, MD, DFAPA, MFPM | Director · Board | Helus Pharma | 1 |
| Gerard Sanacora, M.D., Ph.D. | Scientific Advisory Board · Advisor | Transcend Therapeutics, Inc., Vistagen Therapeutics, Inc. | 2 |
| Glenn Short, Ph.D. | Chief Scientific Officer · Executive | Atai Beckley N.V. (AtaiBeckley), EmpathBio, Inc. | 2 |
| Guy Goodwin, MD | Chief Medical Officer · Executive | COMPASS Pathways plc, Beckley Psytech Limited | 2 |
| Heather Turner, J.D. | Chief Executive Officer · Executive | LB Pharmaceuticals Inc. | 1 |
| Ian Mortimer, MBA, CPA, CMA | President and Chief Executive Officer · Executive | Xenon Pharmaceuticals Inc. | 1 |
| Inderjit Kaul, MD, MPH | Director · Board | Minerva Neurosciences, Inc. | 1 |
| Joaquin Duato | Chairman and Chief Executive Officer · Executive | Johnson & Johnson | 1 |
| Jonathan Sporn, MD | Co-Founder · Founder | Gilgamesh Pharmaceuticals, Inc. | 1 |
| Julie Kim, MBA | Representative Director, President and CEO · Executive | Takeda Pharmaceutical Company Limited | 1 |
| Justin Gover, MBA | Independent Director · Board | COMPASS Pathways plc, Xenon Pharmaceuticals Inc. | 2 |
| Kabir Nath, MA, MBA | Chief Executive Officer · Executive | COMPASS Pathways plc | 1 |
| Kathleen Tregoning, MA | Chief Corporate Affairs Officer · Executive | Cerevel Therapeutics Holdings, Inc., COMPASS Pathways plc | 2 |
| Kevin Finney, MBA | President and Chief Executive Officer · Executive | Autobahn Therapeutics, Inc. | 1 |
| Kyle W. Gano, PhD | Chief Executive Officer · Executive | Neurocrine Biosciences, Inc. | 1 |
| Magnus Halle, BSc | Co-Founder · Founder | GH Research PLC | 1 |
| Michael Hayden, MB, ChB, PhD, FRCP(C), FRSC | Co-Founder · Founder | Xenon Pharmaceuticals Inc., Ionis Pharmaceuticals, Inc. | 2 |
| Michael R. Liebowitz, M.D. | Scientific Advisor · Advisor | Pherin Pharmaceuticals, Inc., Vistagen Therapeutics, Inc. | 2 |
| Mike Poole, M.D. | Co-Founder · Founder | Neumora Therapeutics, Inc. | 1 |
| Nick Smith, BA | Chief Business Officer · Executive | Alto Neuroscience, Inc. | 1 |
| Paul Glavine | Co-Founder · Founder | Helus Pharma | 1 |
| Paul Kelly, MBA | Chief Operating Officer · Executive | Relmada Therapeutics, Inc. | 1 |
| Raymond Sanchez, MD | Chief Medical Officer · Executive | Cerevel Therapeutics Holdings, Inc., Alto Neuroscience, Inc. | 2 |
| Remy Luthringer, PhD | Executive Chairman and Chief Executive Officer · Executive | Minerva Neurosciences, Inc. | 1 |
| Richard Francis | President and Chief Executive Officer · Executive | Teva Pharmaceutical Industries Ltd. | 1 |
| Robert Barrow, MS | Chief Executive Officer · Executive | Definium Therapeutics, Inc. | 1 |
| Robert Berman, MD | Member, Board of Directors · Board | Gilgamesh Pharmaceuticals, Inc., Syndeio Biosciences, Inc. | 2 |
| Robert C. Malenka, MD, PhD | Chairman, Scientific Advisory Board · Advisor | Aelis Farma S.A., Definium Therapeutics, Inc. | 2 |
| Robert Hershberg, MD, PhD | Director · Board | Atai Beckley N.V. (AtaiBeckley), Beckley Psytech Limited | 2 |
| Robert M. Davis | Chairman and Chief Executive Officer · Executive | Merck & Co., Inc. | 1 |
| Ron Renaud | President and Chief Executive Officer · Executive | Cerevel Therapeutics Holdings, Inc. | 1 |
| Sanjay Mathew, M.D. | Scientific Advisor · Advisor | Autobahn Therapeutics, Inc., Vistagen Therapeutics, Inc. | 2 |
| Sergio Traversa, PharmD, MBA | Chief Executive Officer · Executive | Relmada Therapeutics, Inc. | 1 |
| Spyridon "Spyros" Papapetropoulos, MD, PhD | President and Chief Executive Officer · Executive | Neuphoria Therapeutics, Inc. | 1 |
| Srinivas Rao, MD, PhD | Co-Founder · Founder | Atai Beckley N.V. (AtaiBeckley) | 1 |
| Stanley T. Crooke, MD, PhD | Founder · Founder | Ionis Pharmaceuticals, Inc. | 1 |
| Stéphanie Monlezun | Co-Founder · Founder | Aelis Farma S.A. | 1 |
| Steve Brannan, M.D. | Scientific Advisor, Scientific Advisory Board · Advisor | Helus Pharma, Syndeio Biosciences, Inc. | 2 |
| Zachary Prensky | Co-Founder · Founder | LB Pharmaceuticals Inc. | 1 |
| Aaron Bartlone | Chief Operating Officer · Executive | Helus Pharma | 1 |
| Aaron Cameron, MBA | Chief Operating Officer · Executive | GH Research PLC | 1 |
| Adam Koppel, MD, PhD | Director · Board | Cerevel Therapeutics Holdings, Inc. | 1 |
| Adam Savitz, MD, PhD | Chief Medical Officer · Executive | Alto Neuroscience, Inc. | 1 |
| Adeoye Olukotun, MD | Director · Board | Tonix Pharmaceuticals Holding Corp. | 1 |
| Alaa Halawa, MBA | Director · Board | Neumora Therapeutics, Inc. | 1 |
| Alan Crane | Co-Founder and Chairman of the Board · Founder | Navitor Pharmaceuticals, Inc. | 1 |
| Alan Fisher, BCom, FCA | Non-Executive Chair of the Board · Board | Neuphoria Therapeutics, Inc. | 1 |
| Alan Schatzberg, MD | Scientific Advisor · Advisor | Alto Neuroscience, Inc. | 1 |
| Alex Nivorozhkin, PhD | Chief Scientific Officer · Executive | Helus Pharma | 1 |
| Alida Barry | Vice President, Head of Regulatory Affairs · Executive | Autobahn Therapeutics, Inc. | 1 |
| Allene M. Diaz | Director · Board | Ionis Pharmaceuticals, Inc. | 1 |
| Amanda Jones, PharmD | Senior Vice President, Clinical Development · Executive | Transcend Therapeutics, Inc. | 1 |
| Amir Inamdar, MBBS, DNB (Psych), MFPM | Chief Medical Officer · Executive | Helus Pharma | 1 |
| Amir Kalali, MD | Director · Board | Atai Beckley N.V. (AtaiBeckley) | 1 |
| Amy Kruse, PhD | Member, Board of Directors · Board | Gilgamesh Pharmaceuticals, Inc. | 1 |
| Amy Sullivan, B.S. | Chief Human Resources Officer · Executive | Neumora Therapeutics, Inc. | 1 |
| Anantha Shekhar, M.D., Ph.D. | Chief Scientific Advisor · Advisor | Syndeio Biosciences, Inc. | 1 |
| Anders Gersel Pedersen, MD, PhD, MBA | Chairman of the Board · Board | Aelis Farma S.A. | 1 |
| Andrea DiFabio | Chief Legal Officer and Corporate Secretary · Executive | Xenon Pharmaceuticals Inc. | 1 |
| Andrea Heslin Smiley | Director · Board | Atai Beckley N.V. (AtaiBeckley) | 1 |
| Andreas Krebs | Vice Chair of the Board of Directors · Board | Definium Therapeutics, Inc. | 1 |
| Andrew Dreyfus, BA | Director · Board | Alto Neuroscience, Inc. | 1 |
| Andrew Miller, PhD | Director · Board | Alto Neuroscience, Inc. | 1 |
| Andrew Ratz, PhD | Chief Technical Operations Officer · Executive | Neurocrine Biosciences, Inc. | 1 |
| Ann M. Cunningham, MBA | Non-Executive, Non-Independent Director · Board | Vistagen Therapeutics, Inc. | 1 |
| Anne Johnson, CPA | Chief Accounting Officer · Executive | Atai Beckley N.V. (AtaiBeckley) | 1 |
| Anne Sempowski Ward, MBA | Director · Board | Vanda Pharmaceuticals Inc. | 1 |
| Antony Loebel, MD | Chief Medical Officer and President of Clinical Development · Executive | Seaport Therapeutics, Inc. | 1 |
| Ari Maizel, MBA | Chief Commercial Officer · Executive | Axsome Therapeutics, Inc. | 1 |
| Arsène Guekam, PharmD | Chief Corporate Development Officer · Executive | Aelis Farma S.A. | 1 |
| Arvin Ramos | Chief Financial Officer · Executive | Mindset Pharma Inc. | 1 |
| Ashlee Heldreth | Senior Director of Clinical Operations · Executive | Autobahn Therapeutics, Inc. | 1 |
| Au Chun Kwok Alan, CPA, CFA | Independent Non-executive Director · Board | CSPC ZhongQi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | 1 |
| Avi Reichenberg, PhD | Scientific Advisory Board Member · Advisor | Minerva Neurosciences, Inc. | 1 |
| Awny Farajallah, MD | Chief Medical Officer · Executive | Takeda Pharmaceutical Company Limited | 1 |
| Barbara Rothbaum, PhD | Scientific Advisory Board · Advisor | Transcend Therapeutics, Inc. | 1 |
| Ben Cravatt, PhD | Director · Board | Autobahn Therapeutics, Inc. | 1 |
| Benjamin Kelmendi, MD | Co-founder and Chief Scientific Advisor · Founder | Transcend Therapeutics, Inc. | 1 |
| Betsy Vaughn | Vice President, Head of People and Culture · Executive | Autobahn Therapeutics, Inc. | 1 |
| Bill Aurora, Pharm.D. | Chief Operating and Development Officer · Executive | Neumora Therapeutics, Inc. | 1 |
| Blair Jackson | Executive Vice President, Chief Operating Officer · Executive | Alkermes plc | 1 |
| Blake Mandell | Co-founder and Chief Executive Officer · Founder | Transcend Therapeutics, Inc. | 1 |
| Bob Hombach | Board Member and Audit Committee Chair · Board | Seaport Therapeutics, Inc. | 1 |
| Bonnie van Wilgenburg, DPhil | Director · Board | Autobahn Therapeutics, Inc. | 1 |
| Bradley Saenger, CPA | Chief Financial Officer · Executive | Tonix Pharmaceuticals Holding Corp. | 1 |
| Brahim Guetarni | Director · Board | Aelis Farma S.A. | 1 |
| Brandi Roberts, CPA | Chief Financial Officer · Executive | Definium Therapeutics, Inc. | 1 |
| Brent Paul, MBA | Vice President, Marketing & Commercial Operations · Executive | Emalex Biosciences Inc. | 1 |
| Brian Birchler | Executive Vice President, Corporate and Development Operations · Executive | Ionis Pharmaceuticals, Inc. | 1 |
| Brian Kirkpatrick, MD | Scientific Advisory Board Member · Advisor | Minerva Neurosciences, Inc. | 1 |
| Brian P. McKeon | Director, Chair of the Financial Operating Committee · Board | Alkermes plc | 1 |
| Bruce D. Car, DVM, PhD, DACVP | Chief Scientific Officer · Executive | Biohaven Ltd. | 1 |
| Bruce Daugherty, PhD, MBA | Executive Vice President, Research · Executive | Tonix Pharmaceuticals Holding Corp. | 1 |
| C. Frank Bennett, PhD | Executive Vice President, Chief Scientific Officer · Executive | Ionis Pharmaceuticals, Inc. | 1 |
| Cai Dongchen, MBA | Chairman · Executive | CSPC ZhongQi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | 1 |
| Cai Lei, PhD | Vice-Chairman & Chief Executive Officer · Executive | CSPC ZhongQi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | 1 |
| Cai Xin, MBA | Executive Director & Executive President · Executive | CSPC ZhongQi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | 1 |
| Carol A. Vallone | Chair of the Board of Directors · Board | Definium Therapeutics, Inc. | 1 |
| Carol Suh | Co-Founder · Founder | Neumora Therapeutics, Inc. | 1 |
| Carolyn E. Taylor, JD | Director · Board | Tonix Pharmaceuticals Holding Corp. | 1 |
| Catherine Jensen Peña, PhD | Scientific Advisor · Advisor | Autobahn Therapeutics, Inc. | 1 |
| Cato T. Laurencin, MD, PhD | Director · Board | Alkermes plc | 1 |
| Charles Duncan, PhD | Director · Board | Vanda Pharmaceuticals Inc. | 1 |
| Charles Ence, MBA | Chief Accounting and Compliance Officer · Executive | Relmada Therapeutics, Inc. | 1 |
| Charles J. Casamento, RPh, MBA | Chairman of the Board · Board | Relmada Therapeutics, Inc. | 1 |
| Chen Chuan | Independent Non-executive Director · Board | CSPC ZhongQi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | 1 |
| Chen Weiping | Executive Director & Executive President · Executive | CSPC ZhongQi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | 1 |
| Chris Barrett | Senior Vice President, Commercial Strategy, Common Disease · Executive | Biohaven Ltd. | 1 |
| Christine A. Poon | Director · Board | Neurocrine Biosciences, Inc. | 1 |
| Christine H. Soulje, PhD | Senior Director, Product Development · Executive | Emalex Biosciences Inc. | 1 |
| Christoph U. Correll, M.D. | Scientific Advisory Board Member · Advisor | LB Pharmaceuticals Inc. | 1 |
| Christopher Gordon, MBA | Director · Board | Cerevel Therapeutics Holdings, Inc. | 1 |
| Christopher I. Wright, MD, PhD | Director · Board | Alkermes plc | 1 |
| Christopher Kenney, MD | Chief Medical Officer · Executive | Xenon Pharmaceuticals Inc. | 1 |
| Christopher Nixon Cox, JD | Director · Board | Alto Neuroscience, Inc. | 1 |
| Christopher Wilson, MS | Senior Director, Drug Product Development · Executive | Emalex Biosciences Inc. | 1 |
| Christos Polymeropoulos, MD | Senior Vice President, Medical Director · Executive | Vanda Pharmaceuticals Inc. | 1 |
| Chushiro Aoi | Outside Audit & Supervisory Board Member (Taisho Pharmaceutical Holdings) · Board | Taisho Pharmaceutical Co., Ltd. | 1 |
| Cliff Bechtold, MS | President & General Manager, Biohaven Ireland; Chief Compliance Officer · Executive | Biohaven Ltd. | 1 |
| Craig Hopkinson, MD | Executive Vice President, Research & Development and Chief Medical Officer · Executive | Alkermes plc | 1 |
| Cynthia L. Anderson, CPA | Vice President and Chief Financial Officer · Executive | Vistagen Therapeutics, Inc. | 1 |
| Daniel D. Von Hoff, M.D., F.A.C.P. | Immuno-oncology Advisor · Advisor | BioXcel Therapeutics, Inc. | 1 |
| Daniel McGuire | Senior Vice President, General Counsel and Secretary · Executive | Vanda Pharmaceuticals Inc. | 1 |
| Daniel R. Karlin, MD, MA | Chief Medical Officer · Executive | Definium Therapeutics, Inc. | 1 |
| Daniel Umbricht, MD | Head of Clinical Development · Executive | Gilgamesh Pharmaceuticals, Inc. | 1 |
| Daniele Piomelli, PharmD, PhD | Scientific Advisory Board Member · Advisor | Aelis Farma S.A. | 1 |
| Daphne Karydas, MBA | Independent Director · Board | COMPASS Pathways plc | 1 |
| Daphne Zohar | Founder, Chief Executive Officer and Board Member · Executive | Seaport Therapeutics, Inc. | 1 |
| Darin M. Lippoldt, JD | Chief Legal Officer and Corporate Secretary · Executive | Neurocrine Biosciences, Inc. | 1 |
| Darren Cline | Chief Commercial Officer · Executive | Xenon Pharmaceuticals Inc. | 1 |
| Darryl Rideout, PhD | Executive Vice President, Experimental Chemistry · Executive | Tonix Pharmaceuticals Holding Corp. | 1 |
| David Gaffin | Executive Vice President, Chief Legal Officer, Chief Compliance Officer and Secretary · Executive | Alkermes plc | 1 |
| David Grange | Director · Board | Tonix Pharmaceuticals Holding Corp. | 1 |
| David Kim | Associate Vice President, Clinical Operations · Executive | Emalex Biosciences Inc. | 1 |
| David Knouft, MBA | Vice President, Market Access & Patient Services · Executive | Emalex Biosciences Inc. | 1 |
| David Kupfer, MD | Director · Board | Minerva Neurosciences, Inc. | 1 |
| David M. Sabatini, M.D., Ph.D. | Scientific Founder · Founder | Navitor Pharmaceuticals, Inc. | 1 |
| David Mack, LL.B. | Independent Director · Board | BioXcel Therapeutics, Inc. | 1 |
| David Norton | Independent Director · Board | COMPASS Pathways plc | 1 |
| David Piacquad, MBA | Director · Board | Neumora Therapeutics, Inc. | 1 |
| David W. Boyer | Chief Corporate Affairs Officer · Executive | Neurocrine Biosciences, Inc. | 1 |
| David Wheadon, MD | Board Member · Board | Seaport Therapeutics, Inc. | 1 |
| David Wilson | Non-Executive Director · Board | Neuphoria Therapeutics, Inc. | 1 |
| Dawn Svoronos | Chair of the Board · Board | Xenon Pharmaceuticals Inc. | 1 |
| Dean Y. Li, M.D., Ph.D. | Executive Vice President and President, Merck Research Laboratories · Executive | Merck & Co., Inc. | 1 |
| Deborah Baron, MBA | Director · Board | Cerevel Therapeutics Holdings, Inc. | 1 |
| Denice Torres, JD | Board Member · Board | Seaport Therapeutics, Inc. | 1 |
| Dermot Hanley, MBA | Director · Board | GH Research PLC | 1 |
| Deval Patrick, JD | Director · Board | Cerevel Therapeutics Holdings, Inc. | 1 |
| Doug Frandsen | Corporate Controller · Executive | Emalex Biosciences Inc. | 1 |
| Doug Giordano, MBA | Director · Board | Cerevel Therapeutics Holdings, Inc. | 1 |
| Duncan Moore, PhD | Director · Board | GH Research PLC | 1 |
| E. Rene Salas, CPA | Director · Board | Intra-Cellular Therapies, Inc. | 1 |
| Ed Christian, PhD | Translational Medicine Scientist · Executive | Gilgamesh Pharmaceuticals, Inc. | 1 |
| Ekaterina Malievskaia, MD | Co-Founder · Founder | COMPASS Pathways plc | 1 |
| Elissa Cote | Chief Corporate Development Officer · Executive | Vistagen Therapeutics, Inc. | 1 |
| Elizabeth Garofalo, MD | Director · Board | Xenon Pharmaceuticals Inc. | 1 |
| Elizabeth L. Hougen | Executive Vice President, Chief Financial Officer · Executive | Ionis Pharmaceuticals, Inc. | 1 |
| Ellen Freeman, Ph.D. | Scientific Advisor · Advisor | Pherin Pharmaceuticals, Inc. | 1 |
| Ellen Rose | Senior Vice President, Corporate Affairs · Executive | LB Pharmaceuticals Inc. | 1 |
| Ellis F. Unger, MD | Scientific Advisor · Advisor | Autobahn Therapeutics, Inc. | 1 |
| Eric A. Hughes, MD, PhD | Executive Vice President, Global R&D and Chief Medical Officer · Executive | Teva Pharmaceutical Industries Ltd. | 1 |
| Eric Benevich | Chief Commercial Officer · Executive | Neurocrine Biosciences, Inc. | 1 |
| Eric E. Swayze, PhD | Executive Vice President, Research · Executive | Ionis Pharmaceuticals, Inc. | 1 |
| Eric Green, MBA | Chief Operating Officer · Executive | Seaport Therapeutics, Inc. | 1 |
| Eric Hoskins, MD | Director, Chair of Corporate Governance and Nominating Committee · Board | Helus Pharma | 1 |
| Eric Messner, MBA | Chief Executive Officer · Executive | Emalex Biosciences Inc. | 1 |
| Erin R. McQuade, JD | General Counsel and Chief Administrative Officer · Executive | Alto Neuroscience, Inc. | 1 |
| Eugene Schneider, MD | Executive Vice President, Chief Clinical Development and Operations Officer · Executive | Ionis Pharmaceuticals, Inc. | 1 |
| Fabiana Fedeli | Director · Board | Relmada Therapeutics, Inc. | 1 |
| Florian Brand | Co-Founder · Founder | Atai Beckley N.V. (AtaiBeckley) | 1 |
| Fouzia Laghrissi-Thode, MD | Director · Board | Minerva Neurosciences, Inc. | 1 |
| Frank Anders Wilson | Lead Independent Director · Board | Alkermes plc | 1 |
Showing the first 200 of 543.